Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Pan, MON 29 Nov 2010    Austere times demand healthcare efficiency: OECD Fish health benefits may outweigh mercury concerns Vaccine alliance says 5-in-1 vaccine cost to fall Second-hand smoke kills 600,000 a year: WHO study New spermicide may be as good as nonoxynol-9 EU guidelines clear way for biosimilar antibodies Long-time statin users have lower gallstone risk Austere times demand healthcare efficiency: OECD November 29, 2010 08:14 AM ET LONDON (Reuters) - Cash-strapped governments can no longer raise spending to improve healthcare at the breakneck pace of recent decades, so they must make systems more efficient to offer quality care at no extra cost, the OECD said Monday. Full Article Fish health benefits may outweigh mercury concerns November 26, 2010 10:16 AM ET NEW YORK (Reuters Health) - It may be a red herring to worry over whether people who eat lots of fish may lose whatever heart benefits they might have gained because of an increased exposure to mercury, a new study shows. Full Article Vaccine alliance says 5-in-1 vaccine cost to fall November 26, 2010 12:37 PM ET LONDON (Reuters) - The price of a life-saving vaccine against five deadly diseases is expected to drop further in 2011, allowing more of the world's poorest children to be immunized, the global vaccines group GAVI said on Friday. Full Article Second-hand smoke kills 600,000 a year: WHO study November 26, 2010 10:56 AM ET LONDON (Reuters) - Around one in a hundred deaths worldwide is due to passive smoking, which kills an estimated 600,000 people a year, World Health Organization (WHO) researchers said on Friday. Full Article New spermicide may be as good as nonoxynol-9 November 26, 2010 10:14 AM ET NEW YORK (Reuters Health) - A new spermicide compound, not yet available in drugstores, may be as good a contraceptive as the drug now in existing gels, films, and foams, hints a new study. Full Article EU guidelines clear way for biosimilar antibodies November 26, 2010 12:38 PM ET LONDON (Reuters) - European regulators on Friday set out broad guidelines for the approval of biosimilar antibody drugs, including lower hurdles than for new medicines and allowing the possibility of different diseases being addressed by the same copy antibody. Full Article Long-time statin users have lower gallstone risk November 26, 2010 01:13 PM ET NEW YORK (Reuters Health) - People who take cholesterol-lowering statins for at least one to two years appear to be less likely to develop gallstones, a study of nearly two million Danish residents shows. Full Article

REUTERS www.reuters.com Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details Subscribe to other Reuters newsletters Unsubscribe from this newsletter. Send this mailing to a friend or colleague Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers